Trial NCT00395057

View at ClinicalTrials.gov 
Org. Study IDs: 211745-001

Last trial update was posted on 2015-09-07

MeSH Interventions

Ranibizumab

MeSH Conditions

Choroidal Neovascularization Macular Degeneration Neovascularization, Pathologic

Other Conditions

Age-Related Macular Degeneration Choroid Neovascularization

Stopping Reasons

The study was terminated early due to company decision (non-safety related).

Limitations And Caveats

The study was terminated early due to a company decision (non-safety related). Because the study was terminated early, data for certain outcome measures (ie, "Visual Functioning Questionnaire [VFQ] at Month 3") were not analyzed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID